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Abstract 
Background: Persistence of sulfadoxine–pyrimethamine (SP) resistance has been described in an urban setting in 
Malawi where malaria transmission is relatively low. Higher malaria transmission is associated with greater genetic 
diversity and more frequent genetic recombination, which could lead to a more rapid re‑emergence of SP‑sensitive 
parasites, as well as more rapid degradation of selective sweeps. In this study, the impact of local variation in malaria 
transmission on the prevalence of SP‑resistant haplotypes and selective sweep characteristics was investigated at an 
urban site with low parasite prevalence and two rural sites with moderate and high parasite prevalence.
Methods: Samples from three sites with different parasite prevalence were genotyped for resistance markers within 
pfdhfr‑ts and pfdhps and at microsatellites flanking these genes. Expected heterozygosity (He) was estimated to evalu‑
ate genetic diversity.
Results: No difference in the prevalence of highly resistant DHFR 51I/59R/108N and DHPS 437G/540E was found 
between sites. Small differences in He flanking pfdhfr‑ts and pfdhps were seen between rural‑moderate and the other 
sites, as well as some shared haplotypes between the rural‑high and urban‑low sites.
Conclusions: The results do not show an effect of local variation in malaria transmission, as inferred from parasite 
prevalence, on SP‑resistant haplotype prevalence.
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dihydropteroate synthase (DHPS)
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Background
The potential expansion of artemisinin-resistant Plas-
modium falciparum, from Asia to Africa, has heightened 
interest in identifying factors affecting resistance allele 
dynamics, including the re-emergence of drug-sensitive 
malaria parasites. Chloroquine and sulfadoxine–
pyrimethamine (SP) were both once used as safe and 
effective primary treatment for uncomplicated malaria. 
Successive waves of anti-malarial resistance from 
Southeast Asia prompted public health organizations 
to abandon chloroquine, and then SP, in favour of arte-
misinin-based combination therapy (ACT).
After the removal of chloroquine drug pressure in 
Malawi in 1993, chloroquine-sensitive parasites re-
expanded in the population, eventually outcompeting the 
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chloroquine-resistant strains [1]. The return of chloro-
quine sensitivity was shown, via the analysis of selective 
sweeps, to be the result of the re-emergence of geneti-
cally diverse sensitive parasites that had survived selec-
tive pressure [2]. This relatively rapid and nationwide 
re-emergence of genetically diverse drug-sensitive para-
sites in Malawi was unexpected, as drug resistance had 
persisted in South America and Southeast Asia many 
years after reduction in drug pressure [1, 3, 4].
In late 2007, Malawi replaced SP with an ACT in 
response to failing SP efficacy. The persistence of the 
highly resistant haplotypes of dihydrofolate reductase 
(DHFR) and dihydropteroate synthase (DHPS), DHFR 
51I/59R/108N and DHPS 437G/540E, 5  years after the 
reduction of SP drug pressure, was recently demon-
strated by the authors, with discussion of possible causes 
and implications of continued resistance [5]. Selective 
sweep analysis suggested little to no fitness cost of SP 
resistance in the urban setting of Ndirande where local 
transmission intensity is presumed relatively low.
The effect of reduction of SP use on SP-resistant para-
sites has been variable in other regions. While the per-
sistence of SP-resistant parasites in Venezuela was shown 
years after the removal of drug pressure [6], a study of the 
frequency of Peruvian DHFR and DHPS resistance hap-
lotypes showed a decline in DHFR 51I/108N/164L hap-
lotypes within 5 years of SP removal as well as a decline 
in DHPS 437G/540E/581E [7]. Another recent study in 
Kenya observed differential change in genotype preva-
lence between rural-moderate and rural-high transmis-
sion settings 2 years after replacing SP with an ACT [8]. 
It is possible that these differences could be due to differ-
ent background rates of malaria transmission.
Malaria parasites from areas of high transmission tend 
to be more diverse and undergo more recombination [6, 
9, 10]. In the absence of selective pressure, high para-
site diversity and recombination rates begin to increase 
the level of heterozygosity observed around resistance 
loci [6, 11]. Recombination between resistant and sensi-
tive parasites from diverse lineages will begin to increase 
heterozygosity within the resistant parasite population, 
decreasing the width and depth of the selective sweep [6, 
11]. Higher malaria transmission also results in a larger 
proportion of clinically immune hosts that can serve 
as a reservoir of drug-sensitive parasites that can re-
expand after removal of drug pressure [12]. Areas with 
low malaria transmission tend to have lower levels of 
parasite diversity, leading to higher rates of inbreeding 
and more rapid rates of fixation of polymorphisms, pos-
sibly explaining why re-emergence of sensitive parasites 
was not seen in Venezuela. The rate of malaria transmis-
sion throughout Malawi is higher than that observed in 
South America and Southeast Asia, yet relatively higher 
and lower transmission settings can be found in rural 
and urban environments within Malawi. In this study 
the authors estimate the prevalence of DHFR and DHPS 
resistance haplotypes and the characteristics of the asso-
ciated selective sweeps at three sites with low, moderate 
and high parasite prevalence within Malawi to explore 
whether local variation in transmission impacts the re-
expansion of sensitive parasites.
Methods
Samples were collected as part of a malaria surveillance 
study conducted in health facilities in three districts in 
Malawi: a rural site near a river with high parasite preva-
lence (Chikwawa), a rural more arid site with moder-
ate parasite prevalence (Thyolo) and an urban site with 
low parasite prevalence (Ndirande). Samples were col-
lected from individuals presenting to the hospital with 
uncomplicated malaria. All samples were collected with 
informed consent according to an institutional review 
board approved protocol. Samples consisted of blood 
spots, collected on filter papers, representing a patient’s 
initial infection on the day they were admitted to the 
study, prior to treatment. Parasite prevalence from a 
community-based, cross-sectional survey was used as a 
surrogate measure of transmission intensity; 8.4, 14.3 and 
29.6  % of individuals surveyed in the urban-low, rural-
moderate and rural-high settings, respectively, were 
qPCR-positive for P. falciparum parasites. Recent ento-
mological inoculation rates (EIR) were not available for 
these sites, but the use of parasite prevalence as a surro-
gate for EIR and transmission intensity is supported in 
previous studies [13].
DNA was extracted from filter paper blood cards 
using a Qiagen BioRobot (Qiagen, Valencia, CA, USA) 
following the Investigator Bloodcard Protocol. Para-
site genotypes at polymorphic sites within pfdhfr-ts and 
pfdhps genes were determined via pyrosequencing. Sin-
gle nucleotide polymorphisms (SNPs) within codons 51, 
59 and 108, of pfdhfr-ts and codons 437, 540 and 581 
of pfdhps were genotyped for all samples using prim-
ers and amplification methods adapted from Zhou et al. 
[14]. Pyrosequencing was performed on a PyroMark Q96 
MD system (Biotage, Charlotte, NC, USA). Allele fre-
quency was adjusted based on a standard curve [15]. An 
allele with a relative frequency of 80 % or greater within a 
given infection was designated as the predominant allele. 
Haplotypes were constructed using only the predomi-
nant allele. Samples without a predominant allele at two 
or more codons were labelled ‘mixed-genotype’. Samples 
that were mixed at a single codon were treated as con-
taining both possible haplotypes.
To show that reduced heterozygosity around drug 
resistance genes was the result of selection rather than 
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demographic processes, expected heterozygosity was 
measured in six unlinked neutral loci located throughout 
the P. falciparum genome [16]. These unlinked microsat-
ellites were amplified using previously published prim-
ers and amplification conditions [16]. When multiple 
peaks were identified within the same sample, peaks that 
were less than one-third the height of the tallest peak 
were ignored and the tallest peak was designated as the 
predominant allele [16, 17]. Only samples with a pre-
dominant allele were included in estimates of expected 
heterozygosity.
Eight polymorphic microsatellites flanking pfdhfr-ts 
were genotyped; four downstream (+50, +20, +1.48, 
+0.2 kb), and four upstream (−0.3, −1.2, −10, −30 kb) 
using previously described primers and protocols [11, 
18]. Eight polymorphic microsatellites flanking pfdhps 
were genotyped; four downstream (+9.008, +1.407, 
+0.505, +0.034 kb), and four upstream (−0.132, −2.849, 
−7.489, −11.069 kb) of the gene, using primers described 
by Vinayak et al. [19]. Fragment size was visualized using 
an Applied BioSystems 3730XL high-throughput 96-cap-
illary DNA sequencer. Analysis of electropherograms 
was performed using Genemapper software (version 4.0; 
ABI). A Perl script was used to assign the raw electro-
pherogram scores to an integer allele size based on the 
expected repeat length and variation seen in the positive 
controls.
The prevalence of each haplotype was estimated as the 
number of each haplotype observed among the success-
fully genotyped samples for each resistance gene, divided 
by the total number of genotyped samples. Haplotype 
frequency, the proportion of parasites with a given hap-
lotype, could not be calculated as the number of parasite 
clones per infection was not estimated. A resistant haplo-
type was defined as containing any number or combina-
tion of resistance alleles at the genotyped codons within 
either of the resistance genes of interest. The sensitive 
haplotype was defined as parasites with sensitive alleles 
at all codons within both genes. Samples with mixed-
genotype at two or more loci within the same gene were 
excluded because haplotype phase could not be deter-
mined. Chi squared tests with Yate’s correction were 
used, where appropriate.
Expected heterozygosity (He), a measure of genetic 
diversity at each microsatellite locus, was calculated 
using the standard equations for He and variance: 
The analysis focused on sweep characteristics flank-
ing DHFR 51I/59R/108N and DHPS 437G/540E due to 
He =
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limited prevalence of other haplotypes in all three set-
tings. He (±1 standard deviation) was calculated for three 
groups: rural high, rural-moderate and urban-low sites, 
for both pfdhfr-ts and pfdhps genes. Samples without 
a predominant genotype or samples with missing data 
were excluded from expected heterozygosity calculations. 
Statistical significance was determined via permutation. 
Diversity ratios were calculated for Hurban-low/Hrural-high, 
Hurban-low/Hrural-moderate, and Hrural-moderate/Hrural-high. Cal-
culations for He, standard deviation and permutations 
were conducted in R [20].
Results
Of the available samples, complete pfdhfr-ts haplotypes 
were assembled for 549 samples from the urban-low site, 
726 samples from the rural-moderate site, and 660 sam-
ples from the rural-high site (Fig.  1a). Complete pfdhps 
haplotypes were assembled for 546 samples from the 
urban-low site, 733 samples from the rural-moderate site 
and 558 samples from the rural-high site (Fig. 1b). No dif-
ference in the prevalence of the highly resistant DHFR 
51I/59R/108N or DHPS 437G/540E was found between 
the three study sites. Haplotype prevalence of the DHFR 
51I/59R/108N haplotype was >95  % for all study sites. 
The prevalence of the highly resistant DHPS 437G/540E 
was also >95 % for all three sites. A greater prevalence of 
DHFR 59R/108N was found in the rural-moderate site, 
relative to the rural-high site (0 vs 2 %, Yate’s corrected 
p = 0.020), and was borderline different from the urban-
low site (1 vs 2 %, p = 0.067). A single, sensitive parasite 
infection was identified in the rural-moderate site.
A sub-set of samples was subjected to microsatel-
lite analyses to examine selective sweep characteristics 
between study sites. Of the sub-set, complete microsat-
ellite haplotypes were generated for the rural-moderate 
site (n =  15, pfdhfr-ts), (n =  21, pfdhps), rural-high site 
(n = 10, pfdhfr-ts), (n = 18, pfdhps), and urban-low site 
(n =  15, pfdhfr-ts) and (n =  20, pfdhps). Average He at 
unlinked microsatellites was 0.898. The proportion of 
samples scored as polyclonal based on unlinked micro-
satellites did not differ significantly between study sites 
(p  =  0.611). None of the sites had He values that were 
consistently different from each other (Fig. 2). Significant 
changes in He, were seen between the rural-moderate 
site, and the rural-high site and urban-low site (p < 0.001) 
though no differences between the rural-high and urban-
low sites were found. Analysis of flanking microsatel-
lites indicated the presence of a core haplotype flanking 
pfdhfr-ts and pfdhps, likely of Southeast Asian origin, in 
all three sites (see Additional file  1). Lastly, microsatel-
lite haplotypes flanking pfdhps found in the urban-low 
and rural-high sites were observed that were not present 
in the rural-moderate site, and microsatellite haplotypes 
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found in the rural-moderate site not found in the other 
two locations (Fig. 3).
Discussion
This study estimates the effect of local differences in 
malaria transmission, as inferred from parasite preva-
lence, on the prevalence of SP-resistant haplotypes and 
the characteristics of associated selective sweeps within 
Malawi. Despite marked differences in the parasite prev-
alence between the rural-high and urban low sites, no 
difference in haplotype prevalence or sweep character-
istics was observed. Statistically significant differences 
between the prevalence of DHFR double mutants in the 
rural-moderate and rural-high sites are possibly a statisti-
cal artifact due to large sample size and are not consid-
ered clinically relevant.
This study also indicated similarity in sweep characteris-
tics and some shared microsatellite haplotypes between the 
rural-high and urban-low sites, counter to what would be 
expected under the assumption that higher transmission 
would result in greater genetic diversity. These findings may 
indicate a shared parasite population between these loca-
tions. The divergence of some sweep characteristics and 
microsatellite haplotypes in the rural-moderate site com-
pared to the other two sites, suggests that regional demo-
graphic events may affect sweep characteristics, without 
Fig. 1 Sulfadoxine–pyrimethamine‑resistant haplotype prevalence at three sites with different prevalence of malaria parasites. Haplotype preva‑
lence at DHFR (a) and DHPS (b) at three sites within Malawi: a rural site with high parasite prevalence (Chikwawa), a rural site with moderate parasite 
prevalence (Thyolo), and an urban site with low parasite prevalence (Ndirande). Prevalence was calculated as the percentage of individuals with a 
given haplotype. Error bars represent 95 % confidence intervals
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a significant effect on haplotype prevalence. Such events 
could have been the migration of SP-resistant haplotypes of 
diverse genetic background to the rural-moderate site (per-
haps from neighbouring Mozambique).
The similarity in the proportion of samples scored as 
polyclonal between study sites may indicate similarity in 
the level of malaria transmission, not reflected in the par-
asite prevalence observed at each site. Recent EIRs were 
unavailable for these study sites; therefore, parasite preva-
lence was used as a surrogate for transmission intensity. If 
parasite prevalence was an accurate estimation of transmis-
sion intensity in this study, a larger proportion of polyclonal 
samples in the higher transmission sites would have been 
expected. This discrepancy could indicate that parasite 
prevalence is not a good surrogate for transmission inten-
sity in this study. The estimation of transmission intensity 
used here was based on average parasite prevalence from 
a community-based, district-wide, cross-sectional survey, 
while the data-set used in this study was based on a facil-
ity-based survey. The cross-sectional data provide a single 
Fig. 2 Sulfadoxine–pyrimethamine selective sweep characteristics at three sites with different prevalence of malaria parasites. Expected heterozy‑
gosity in microsatellite loci flanking DHFR 51I/59R/108N (a) and DHPS 437G/540E (b). Samples with missing data were excluded. Error bars represent 
±1 standard deviation. Dashed lines represent genomic level, average He, based on unlinked loci. Alpha <0.05 asterisk indicates significant difference 
between two study sites based on permutation
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estimate of parasite prevalence at a given point in time, and 
may not reflect historical differences in transmission inten-
sity between the sites. It is possible that individuals report-
ing to the district health centres in this study may have been 
from areas with more similar malaria transmission than the 
district-wide average parasite prevalence suggests. It is also 
possible that the almost three-fold difference in parasite 
prevalence between these sites is not sufficient to produce 
a measurable difference in the proportion of polyclonal 
infections, haplotype prevalence, or sweep characteristics.
The data also indicate a Southeast Asian origin of the 
Malawian pfdhfr-ts haplotype based on similarity in 
microsatellite repeat length between Malawian parasites 
and the V1S control strain. While, the Malawian pfdhps 
haplotype in this study differed at several markers from 
the V1S strain, core markers (those in close proximity 
to pfdhps) were similar to those published by Mita et al., 
and Alam et  al. showing similar core haplotypes found 
in Malawi, Bangladesh, Thailand and Cambodia [21, 22]. 
The lack of published microsatellite data for reference 
strains makes direct comparison between publications 
difficult, but these data suggest a Southeast Asian origin 
of the pfdhps resistance allele in Malawi.
This research presents evidence that after nearly two 
decades of high SP resistance in Malawi, differences in 
regional malaria transmission, as inferred from parasite 
prevalence, do not impact the prevalence of SP-resistant 
parasite haplotypes. The SP-resistant haplotypes, DHFR 
51I/59R/108N and DHPS 437G/540E, have maintained 
their high prevalence long after the removal of SP as the 
first-line treatment in multiple settings in Malawi. Inves-
tigators working in epidemiologically similar settings can 
reasonably assume similarity in SP-resistant haplotype 
prevalence and sweep characteristics between local sites 
with different parasite prevalence.
Abbreviations
ACT: artemisinin‑based combination therapy; pfdhfr‑ts: dihydrofolate 
reductase‑thymidylate synthase (gene); pfdhps: dihydropteroate synthase 
(gene); DHFR: dihydrofolate reductase; DHPS: dihydropteroate synthase; 
EIR: entomological inoculation rate; ICEMR: International Center for Excel‑
lence in Malaria Research; PCR: polymerase chain reaction; qPCR: quantita‑
tive polymerase chain reaction; SNP: single nucleotide polymorphism; SP: 
sulfadoxine–pyrimethamine.
Authors’ contributions
EA helped conceive of the study, generated molecular data, analysed the data, 
and drafted the manuscript. AK‑T, PP, ON, MKL, DM, and TET designed and led 
the clinical study from which samples were obtained. SB and SJ generated 
molecular data. AAE, MKL and ST‑H conceived of the study. MKL and ST‑H 
contributed to the writing of the manuscript. All authors read and approved 
the final manuscript.
Author details
1 Howard Hughes Medical Institute/Center for Vaccine Development, Uni‑
versity of Maryland School of Medicine, 685 West Baltimore Street, HSF1‑480, 
Baltimore, MD 21201, USA. 2 Malaria Alert Center, Blantyre, Malawi. 3 Blantyre 
Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi. 
4 University of Maryland, Baltimore County, Baltimore, MD, USA. 5 Institute 
for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, 
USA. 
Acknowledgements
We thank Kathy Strauss, Matthew Adams, Malathi Vadla and other laboratory 
staff of the Center for Vaccine Development Malaria Group for their contribu‑
tions to assay optimization and DNA extraction. We also acknowledge the 
University of Maryland School of Medicine sequencing core where all micro‑
satellite genotyping assays were run. In addition we thank the Molecular and 
Genomics Core facility and the Department of Biochemistry at the University 
of Malawi College of Medicine and the study participants and their parents for 
their participation as well as the staff and field teams from the Malaria Alert 
Center and Blantyre Malaria Project for their technical assistance. This research 
was funded by the following Grants: NIH U01‑AI47858, NIH U19‑AI089683, NIH 
R01‑GM084320, NIH R01‑AI101713 and NIH U01‑AI044824.
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Received: 10 June 2015   Accepted: 22 August 2015
References
 1. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala 
SL, et al. Return of chloroquine antimalarial efficacy in Malawi. N Engl J 
Med. 2006;355:1959–66.
Additional file
Additional file 1: DHFR and DHPS microsatellite haplotypes. 
Description: Table of DHFR and DHPS microsatellite haplotypes. Reference 
strains V1S, 3D7 and HB3. “C”=Chikwawa, rural‑high, “T”=Thyolo, rural‑
moderate, and “N”=Ndirande, urban‑low. Mita 2011 (22) and Alam 2011 
(21) refer to other publications which provide microsatellite haplotypes 
identified and shared between Southeast Asian and Malawian parasites at 
the pfdhps locus.
22%
5%
0%
54%
19%
DHPS 437G/540E
Urban-low + Rural-high
Urban-low + Rural-moderate
Rural-moderate + Rural-high
Unique to single setting
Found in all settings
Fig. 3 Proportion of unique versus common microsatellite haplo‑
types between study sites. Proportion of microsatellite haplotypes 
found between study sites
Page 7 of 7Artimovich et al. Malar J  (2015) 14:387 
 2. Laufer MK, Takala‑Harrison S, Dzinjalamala FK, Stine OC, Taylor TE, Plowe 
CV. Return of chloroquine‑susceptible falciparum malaria in Malawi was a 
reexpansion of diverse susceptible parasites. J Infect Dis. 2010;202:801–8.
 3. Wellems TE, Plowe CV. Chloroquine‑resistant malaria. J Infect Dis. 
2001;184:770–6.
 4. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Arte‑
misinin resistance in Plasmodium falciparum malaria. N Engl J Med. 
2009;361:455–67.
 5. Artimovich E, Schneider K, Taylor TE, Kublin JG, Dzinjalamala FK, Escalante 
AA, et al. Persistence of sulfadoxine–pyrimethamine resistance despite 
reduction of drug pressure in Malawi. J Infect Dis. 2015;212:694–701.
 6. McCollum AM, Mueller K, Villegas L, Udhayakumar V, Escalante AA. 
Common origin and fixation of Plasmodium falciparum dhfr and dhps 
mutations associated with sulfadoxine–pyrimethamine resistance in a 
low‑transmission area in South America. Antimicrob Agents Chemother. 
2007;51:2085–91.
 7. Zhou Z, Griffing SM, de Oliveira AM, McCollum AM, Quezada WM, 
Arrospide N, et al. Decline in sulfadoxine–pyrimethamine‑resistant alleles 
after change in drug policy in the Amazon region of Peru. Antimicrob 
Agents Chemother. 2008;52:739–41.
 8. Vardo‑Zalik AM, Zhou G, Zhong D, Afrane YA, Githeko AK, Yan G. 
Alterations in Plasmodium falciparum genetic structure two years after 
increased malaria control efforts in western Kenya. Am J Trop Med Hyg. 
2013;88:29–36.
 9. Paul RE, Hackford I, Brockman A, Muller‑Graf C, Price R, Luxemburger C, 
et al. Transmission intensity and Plasmodium falciparum diversity on the 
northwestern border of Thailand. Am J Trop Med Hyg. 1998;58:195–203.
 10. Lumb V, Das MK, Singh N, Dev V, Khan W, Sharma YD. Multiple origins of 
Plasmodium falciparum dihydropteroate synthetase mutant alleles associ‑
ated with sulfadoxine resistance in India. Antimicrob Agents Chemother. 
2011;55:2813–7.
 11. Nash D, Nair S, Mayxay M, Newton PN, Guthmann JP, Nosten F, et al. 
Selection strength and hitchhiking around two anti‑malarial resistance 
genes. Proc Biol Sci. 2005;272:1153–61.
 12. Snow RW, Omumbo JA, Lowe B, Molyneux CS, Obiero JO, Palmer A, 
et al. Relation between severe malaria morbidity in children and level of 
Plasmodium falciparum transmission in Africa. Lancet. 1997;349:1650–4.
 13. Manjurano A, Okell L, Lukindo T, Reyburn H, Olomi R, Roper C, et al. Asso‑
ciation of sub‑microscopic malaria parasite carriage with transmission 
intensity in north‑eastern Tanzania. Malar J. 2011;10:370.
 14. Zhou Z, Poe AC, Limor J, Grady KK, Goldman I, McCollum AM, et al. 
Pyrosequencing, a high‑throughput method for detecting single 
nucleotide polymorphisms in the dihydrofolate reductase and dihydrop‑
teroate synthetase genes of Plasmodium falciparum. J Clin Microbiol. 
2006;44:3900–10.
 15. Lumb V, Das MK, Singh N, Dev V, Wajihullah, Sharma YD. Characteristics of 
genetic hitchhiking around dihydrofolate reductase gene associated with 
pyrimethamine resistance in Plasmodium falciparum isolates from India. 
Antimicrob Agents Chemother. 2009;53:5173–80.
 16. Nair S, Williams JT, Brockman A, Paiphun L, Mayxay M, Newton PN, et al. A 
selective sweep driven by pyrimethamine treatment in southeast asian 
malaria parasites. Mol Biol Evol. 2003;20:1526–36.
 17. Lim P, Chy S, Ariey F, Incardona S, Chim P, Sem R, et al. pfcrt polymorphism 
and chloroquine resistance in Plasmodium falciparum strains isolated in 
Cambodia. Antimicrob Agents Chemother. 2003;47:87–94.
 18. Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, et al. 
Antifolate antimalarial resistance in southeast Africa: a population‑based 
analysis. Lancet. 2003;361:1174–81.
 19. Vinayak S, Alam MT, Mixson‑Hayden T, McCollum AM, Sem R, Shah NK, 
et al. Origin and evolution of sulfadoxine resistant Plasmodium falciparum. 
PLoS Pathog. 2010;6:e1000830.
 20. Development CTR. R: a language and environment for statistical comput‑
ing. R Foundation for Statistical Computing. 2008.
 21. Alam MT, Vinayak S, Congpuong K, Wongsrichanalai C, Satimai W, Slutsker 
L, et al. Tracking origins and spread of sulfadoxine‑resistant Plasmodium 
falciparum dhps alleles in Thailand. Antimicrob Agents Chemother. 
2011;55:155–64.
 22. Mita T, Venkatesan M, Ohashi J, Culleton R, Takahashi N, Tsukahara T, 
et al. Limited geographical origin and global spread of sulfadoxine‑
resistant dhps alleles in Plasmodium falciparum populations. J Infect Dis. 
2011;204:1980–8.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
